Kurkumin Meningkatkan Sensitivitas Sel Kanker Payudara terhadap Tamoksifen Melalui Penghambatan Ekspresi P-glikoprotein dan Breast Cancer Resistance Protein

The decreasing of sensitivity or resistance to tamoxifen occured after long-term treatment in breast cancer. One of the major factor in tamoxifen resistance is over expression of efflux transporter P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP). Curcumin has known as inhibitor of...

Full description

Saved in:
Bibliographic Details
Main Authors: Erlia Anggrainy Sianipar (Author), Melva Louisa (Author), Septelia Inawati Wanandi (Author)
Format: Book
Published: Universitas Tadulako, 2018-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3f3391af9f1c4defba5a9c23d24ea42d
042 |a dc 
100 1 0 |a Erlia Anggrainy Sianipar  |e author 
700 1 0 |a Melva Louisa  |e author 
700 1 0 |a Septelia Inawati Wanandi  |e author 
245 0 0 |a Kurkumin Meningkatkan Sensitivitas Sel Kanker Payudara terhadap Tamoksifen Melalui Penghambatan Ekspresi P-glikoprotein dan Breast Cancer Resistance Protein 
260 |b Universitas Tadulako,   |c 2018-04-01T00:00:00Z. 
500 |a 2442-7284 
500 |a 2442-8744 
500 |a 10.22487/j24428744.2018.v4.i1.9209 
520 |a The decreasing of sensitivity or resistance to tamoxifen occured after long-term treatment in breast cancer. One of the major factor in tamoxifen resistance is over expression of efflux transporter P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP). Curcumin has known as inhibitor of P-gp and BCRP. The addition of curcumin to the tamoxifen resistant cells is expected to increase the sensitivity of breast cancer cells to tamoxifen. This study aim to know the effect of curcumin in increasing the cell sensitivity to tamoxifen through inhibition of P-gp and BCRP transporter efflux. MCF-7 breast cancer cell line was induced with tamoxifen 1 µM for 10 passage (MCF-7(T)), then cell viability and mRNA expression of P-gp and BCRP were analyzed. To the MCF-7(T) cells, curcumin was given at of 5/10/20 µM with or without tamoxifen for 5 days and cell viability and mRNA expression of P-gp and BCRP were analyzed on day 5th.  As positive control, verapamil 50 µM was used as P-gp inhibitor, ritonavir 15 µM and nelfinavir 15 µM were used as BCRP inhibitor.  The results showed that MCF-7(T) cells sensitivity to tamoxifen decreased with 11.8 times, the cell viability increased 10.82 fold and mRNA expression of P-gp and BCRP increased 4.04 fold. Then after administration of curcumin with or without tamoxifen for 5 days, the cell viability and the mRNA expression of P-gp and BCRP decreased. As conclusion, curcumin increased the sensitivity of MCF-7(T) to tamoxifen characterized by the decreasing of cell viability and mRNA expression of P-gp and BCRP. However, the administration of combination of curcumin with tamoxifen was more potent than just curcumin. The increased sensitivity was estimated at least partly through the inhibition of P-gp and BCRP mRNA expression by curcumin 
546 |a EN 
546 |a ID 
690 |a Tamoksifen, Kurkumin, P-glikoprotein, BCRP 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Jurnal Farmasi Galenika (Galenika Journal of Pharmacy), Vol 4, Iss 1, Pp 1-11 (2018) 
787 0 |n http://jurnal.untad.ac.id/jurnal/index.php/Galenika/article/view/9209 
787 0 |n https://doaj.org/toc/2442-7284 
787 0 |n https://doaj.org/toc/2442-8744 
856 4 1 |u https://doaj.org/article/3f3391af9f1c4defba5a9c23d24ea42d  |z Connect to this object online.